PLSE Live signals | Maximize Profits with Getagraph.com

SELL 94176 min ago

@ $8.30

Issued: 14 Feb 2024 @ 11:33

Return: -13.37%

Previous signal: Feb 13 - 09:30

Previous signal: Buy

Return: 2.85 %

Live Chart Being Loaded With Signals

Commentary (19 Apr 2024 @ 16:00):

Stats
Today's Volume	178 647
Average Volume	173 998
Market Cap	397.07M
EPS	$0 ( 2024-03-28 )
Next earnings date	( $0 ) 2024-05-08
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-8.17
ATR14	$0.0170 (0.24%)

Insider Trading

Date	Person	Action	Amount	type
2023-12-12	Duggan Robert W	Buy	17 999	Common Stock
2023-12-11	Duggan Robert W	Buy	90 118	Common Stock
2023-12-08	Duggan Robert W	Buy	116 656	Common Stock
2023-12-07	Duggan Robert W	Buy	74 852	Common Stock
2023-12-06	Duggan Robert W	Buy	82 813	Common Stock

INSIDER POWER
93.06
Last 100 transactions
Buy: 20 161 529 \| Sell: 636 131

Volume Correlation

Long: 0.10 (neutral)

Short: 0.57 (weak)

Signal:(67.541) Neutral

Pulse Biosciences Inc Correlation

10 Most Positive Correlations
EVCM	0.877
RBNC	0.868
CDZIP	0.865
HCM	0.863
QFIN	0.863
NLSP	0.863
EEFT	0.86
CPSS	0.858
BKCH	0.855
BYFC	0.852

10 Most Negative Correlations
ZENV	-0.867
GRIN	-0.863
MARK	-0.855
RIVN	-0.855
JAN	-0.839
ENPH	-0.838
SOPA	-0.828
SMMF	-0.82
UTME	-0.817
OP	-0.817

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Pulse Biosciences Inc Correlation - Currency/Commodity

-0.65
( weak negative )

-0.24
( neutral )

0.00
( neutral )

-0.67
( moderate negative )

-0.69
( moderate negative )

0.67
( moderate )

Pulse Biosciences Inc Financials

Annual	2023
Revenue:	$0
Gross Profit:	$-1.21M (0.00 %)
EPS:	$-0.880

Q4	2023
Revenue:	$0
Gross Profit:	$-304 000 (0.00 %)
EPS:	$-0.220

Q3	2023
Revenue:	$0
Gross Profit:	$-266 000 (0.00 %)
EPS:	$-0.190

Q2	2023
Revenue:	$0
Gross Profit:	$-302 000 (0.00 %)
EPS:	$-0.220

Financial Reports:

No articles found.

Pulse Biosciences Inc

Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. It offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using its Nano-Pulse Stimulation technology. The company was formerly known as Electroblate, Inc. and changed its name to Pulse Biosciences, Inc. in December 2015. Pulse Biosciences, Inc. was incorporated in 2014 and is headquartered in Hayward, California.